Skip to main content
Premium Trial:

Request an Annual Quote

MDS Sciex, Eksigent in Proteomics Co-Marketing Pact

NEW YORK June 3 - MDS Sciex will co-market and distribute microfluidics technology for proteomics research developed by Eksigent Technologies, the companies said today.


MDS Sciex will globally co-market and distribute Eksigent's NanoLC system, a high-performance liquid chromatography system for nanoscale liquid chromatography/mass spectrometry experiments.


According to Eksigent, the NanoLC system can be used as stand-alone product or in LC/MS identification of peptides for proteomics studies.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.